Abstract
Many organs (skin, stomach, intestines, colon, and eye) possess an epithelial layer that is short-lived and rapidly lost, requiring a source of adult stem cells that produces a continual supply of epithelial cells to replenish the lost cells. Maintaining these rapidly self-renewing epithelial surfaces during normal homeostasis is therefore dependent upon the health of the adult stem cell population. One important challenge in regenerative medicine is replacing these adult stem cells when they are eliminated following an injury or disease. The eye contains two highly specialized stratified squamous epithelia, the conjunctival epithelium and the corneal epithelium, which are separated by the limbal epithelium (Fig. 5.1). A healthy corneal epithelium is essential for maintaining a clear cornea and normal vision. The limbus contains a small subpopulation of rare LSC (Limbal Stem Cells) that continually repopulates the corneal epithelium. Patients with a LSCD (Limbal Stem Cell Deficiency) are unable to regenerate the corneal epithelium, resulting in migration of the conjunctival epithelium over the corneal stroma, called “conjunctivalization,” that triggers neovascularization, chronic inflammation, and corneal opacity. A complete LSCD results in the total loss of the corneal epithelium and blindness due to an irreversibly opaque cornea. The extent of LSC loss can range from partial to complete and can be either unilateral or bilateral with a corresponding range in the loss of vision. LSCD can be caused by a variety of injuries or diseases: chemical or thermal burns [1], Stevens-Johnson syndrome [2, 3], aniridia [3], contact lens-induced keratopathy [4], multiple surgeries [5], cryotherapy of the limbus [5], chronic peripheral corneal inflammation [6], and lysosomal storage disease. However, corneal burns are by far the most frequent cause of a LSCD [5].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Shanbhag, S. S., Saeed, H. N., Paschalis, E. I., & Chodosh, J. (2017). Keratolimbal allograft for limbal stem cell deficiency after severe corneal chemical injury: A systematic review. The British Journal of Ophthalmology, pii, bjophthalmol–2017–311249. https://doi.org/10.1136/bjophthalmol-2017-311249
Kim, Y. H., Kim, D. H., Shin, E. J., Lee, H. J., Wee, W. R., Jeon, S., et al. (2016). Comparative analysis of substrate-free cultured oral mucosal epithelial cell sheets from cells of subjects with and without Stevens- Johnson syndrome for use in ocular surface reconstruction. PLoS One, 11, e0147548. https://doi.org/10.1371/journal.pone.0147548
Shortt, A. J., Bunce, C., Levis, H. J., Blows, P., Dore, C. J., Vernon, A., et al. (2014). Three-year outcomes of cultured limbal epithelial allografts in aniridia and Stevens-Johnson syndrome evaluated using the clinical outcome assessment in surgical trials assessment tool. Stem Cells Translational Medicine, 3, 265–275. https://doi.org/10.5966/sctm.2013-0025
Rossen, J., Amram, A., Milani, B., Park, D., Harthan, J., Joslin, C., et al. (2016). Contact lens-induced limbal stem cell deficiency. The Ocular Surface, 14, 419–434. https://doi.org/10.1016/j.jtos.2016.06.003
Vazirani, J., Nair, D., Shanbhag, S., Wurity, S., Ranjan, A., & Sangwan, V. (2018). Limbal stem cell deficiency-demography and underlying causes. American Journal of Ophthalmology, 188, 99–103. https://doi.org/10.1016/j.ajo.2018.01.020
Sotozono, C., Inatomi, T., Nakamura, T., Koizumi, N., Yokoi, N., Ueta, M., et al. (2014). Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity. Acta Ophthalmologica, 92, e447–e453. https://doi.org/10.1111/aos.12397
Kenyon, K. R., & Tseng, S. C. (1989). Limbal autograft transplantation for ocular surface disorders. Ophthalmology. https://doi.org/10.1016/S0161-6420(89)32833-8
Pellegrini, G., Ardigò, D., Milazzo, G., Iotti, G., Guatelli, P., Pelosi, D., et al. (2018). Navigating market authorization: The path holoclar took to become the first stem cell product approved in the European Union. Stem Cells Translational Medicine, 7, 146–154. https://doi.org/10.1002/sctm.17-0003
Barker, N., Bartfeld, S., & Clevers, H. (2010). Tissue-resident adult stem cell populations of rapidly self-renewing organs. Cell Stem Cell, 7, 15–15. https://doi.org/10.1016/j.stem.2010.11.016
Richardson, A., Lobo, E. P., Delic, N. C., Myerscough, M. R., Lyons, J. G., Wakefield, D., et al. (2017). Keratin-14-positive precursor cells spawn a population of migratory corneal epithelia that maintain tissue mass throughout life. Stem Cell Reports, 9, 1081–1096. https://doi.org/10.1016/j.stemcr.2017.08.015
Kasetti, R. B., Gaddipati, S., Tian, S., Xue, L., Kao, W. W., Lu, Q., et al. (2016). Study of corneal epithelial progenitor origin and the Yap1 requirement using keratin 12 lineage tracing transgenic mice. Scientific Reports, 6, 35202. https://doi.org/10.1038/srep35202
Dora, N. J., Hill, R. E., Collinson, J. M., & West, J. D. (2015). Lineage tracing in the adult mouse corneal epithelium supports the limbal epithelial stem cell hypothesis with intermittent periods of stem cell quiescence. Stem Cell Research, 15(3), 665–677. https://doi.org/10.1016/j.scr.2015.10.016
Gonzalez, G., Sasamoto, Y., Ksander, B. R., Frank, M. H., & Frank, N. Y. (2018). Limbal stem cells: Identity, developmental origin, and therapeutic potential. Wiley Interdisciplinary Reviews: Developmental Biology, 7, e303. https://doi.org/10.1002/wdev.303
Thoft, R. A. R., & Friend, J. J. (1983). The X, Y, Z hypothesis of corneal epithelial maintenance. Investigative Ophthalmology & Visual Science, 24, 1442–1443.
Cotsarelis, G., Cheng, S.-Z., Dong, G., Sun, T. T., & Lavker, R. M. (1989). Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: Implications on epithelial stem cells. Cell, 57, 201–209. https://doi.org/10.1016/0092-8674(89)90958-6
Pellegrini, G., Golisano, O., Paterna, P., Lambiase, A., Bonini, S., Rama, P., et al. (1999). Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. The Journal of Cell Biology, 145, 769–782. https://doi.org/10.1083/jcb.145.4.769
Pellegrini, G., Traverso, C. E., Franzi, A. T., Zingirian, M., Cancedda, R., & De Luca, M. (1997). Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet, 349, 990–993. https://doi.org/10.1016/S0140-6736(96)11188-0
Pellegrini, G., Dellambra, E., Golisano, O., Martinelli, E., Fantozzi, I., Bondanza, S., et al. (2001). p63 identifies keratinocyte stem cells. Proceedings of the National Academy of Sciences of the United States of America, 98, 3156–3161. https://doi.org/10.1073/pnas.061032098
Di Iorio, E., Barbaro, V., Ruzza, A., Ponzin, D., Pellegrini, G., & De Luca, M. (2005). Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration. Proceedings of the National Academy of Sciences of the United States of America, 102, 9523–9528. https://doi.org/10.1073/pnas.0503437102
Melino, G., Memmi, E. M., Pelicci, P. G., & Bernassola, F. (2015). Maintaining epithelial stemness with p63. Science Signaling, 8, re9–re9. https://doi.org/10.1126/scisignal.aaa1033
Truong, A. B., Kretz, M., Ridky, T. W., Kimmel, R., & Khavari, P. A. (2006). p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes & Development, 20, 3185–3197. https://doi.org/10.1101/gad.1463206
Liang, L., Sheha, H., Li, J., & Tseng, S. C. G. (2009). Limbal stem cell transplantation: New progresses and challenges. Eye (London, England), 23, 1946–1953. https://doi.org/10.1038/eye.2008.379
Pellegrini, G., Rama, P., Matuska, S., Lambiase, A., Bonini, S., Pocobelli, A., et al. (2013). Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells. Regenerative Medicine, 8, 553–567. https://doi.org/10.2217/rme.13.43
Shortt, A. J., Tuft, S. J., & Daniels, J. T. (2010). Ex vivo cultured limbal epithelial transplantation. A clinical perspective. The Ocular Surface, 8, 80–90.
Rama, P., Matuska, S., Paganoni, G., Spinelli, A., De Luca, M., & Pellegrini, G. (2010). Limbal stem-cell therapy and long-term corneal regeneration. The New England Journal of Medicine, 363, 147–155. https://doi.org/10.1056/NEJMoa0905955
Szabó, D. J., Noer, A., Nagymihály, R., Josifovska, N., Andjelic, S., Vereb, Z., et al. (2015). Long-term cultures of human cornea limbal explants form 3D structures ex vivo–implications for tissue engineering and clinical applications. PLoS One, 10, e0143053. https://doi.org/10.1371/journal.pone.0143053
Cheung, A. Y., & Holland, E. J. (2017). Keratolimbal allograft. Current Opinion in Ophthalmology, 28, 377–381. https://doi.org/10.1097/ICU.0000000000000374
Basu, S., Sureka, S. P., Shanbhag, S. S., Kethiri, A. R., Singh, V., & Sangwan, V. S. (2016). Simple limbal epithelial transplantation: Long-term clinical outcomes in 125 cases of unilateral chronic ocular surface burns. Ophthalmology, 123, 1000–1010. https://doi.org/10.1016/j.ophtha.2015.12.042
Sasine, J. P., Yeo, K. T., & Chute, J. P. (2017). Concise review: Paracrine functions of vascular niche cells in regulating hematopoietic stem cell fate. Stem Cells Translational Medicine, 6, 482–489. https://doi.org/10.5966/sctm.2016-0254
González, S., Chen, L., & Deng, S. X. (2017). Comparative study of xenobiotic-free media for the cultivation of human limbal epithelial stem/progenitor cells. Tissue Engineering. Part C, Methods, 23, 219–227. https://doi.org/10.1089/ten.tec.2016.0388
Mei, H., Nakatsu, M. N., Baclagon, E. R., & Deng, S. X. (2014). Frizzled 7 maintains the undifferentiated state of human limbal stem/progenitor cells. Stem Cells, 32, 938–945. https://doi.org/10.1002/stem.1582
Nakatsu, M. N., Ding, Z., Ng, M. Y., Truong, T. T., Yu, F., & Deng, S. X. (2011). Wnt/β-catenin signaling regulates proliferation of human cornea epithelial stem/progenitor cells. Investigative Ophthalmology & Visual Science, 52, 4734–4741. https://doi.org/10.1167/iovs.10-6486
Chan, E., Le, Q., Codriansky, A., Hong, J., Xu, J., & Deng, S. X. (2016). Existence of normal limbal epithelium in eyes with clinical signs of total limbal stem cell deficiency. Cornea, 35, 1483–1487. https://doi.org/10.1097/ICO.0000000000000914
Le, Q., Xu, J., & Deng, S. X. (2018). The diagnosis of limbal stem cell deficiency. The Ocular Surface, 16, 58–69. https://doi.org/10.1016/j.jtos.2017.11.002
Zarei-Ghanavati, S., Ramirez-Miranda, A., & Deng, S. X. (2011). Limbal lacuna: A novel limbal structure detected by in vivo laser scanning confocal microscopy. Ophthalmic Surgery, Lasers & Imaging, 42, e129–e131. https://doi.org/10.3928/15428877-20111201-07
Holland, E. J., Mogilishetty, G., Skeens, H. M., Hair, D. B., Neff, K. D., Biber, J. M., et al. (2012). Systemic immunosuppression in ocular surface stem cell transplantation: Results of a 10-year experience. Cornea, 31, 655–661. https://doi.org/10.1097/ICO.0b013e31823f8b0c
Eslani, M., Haq, Z., Movahedan, A., Moss, A., Baradaran-Rafii, A., Mogilishetty, G., et al. (2017). Late acute rejection after allograft limbal stem cell transplantation: Evidence for long-term donor survival. Cornea, 36, 26–31. https://doi.org/10.1097/ICO.0000000000000970
Han, E. S., Wee, W. R., Lee, J. H., & Kim, M. K. (2011). Long-term outcome and prognostic factor analysis for keratolimbal allografts. Graefe’s Archive for Clinical and Experimental Ophthalmology, 249, 1697–1704. https://doi.org/10.1007/s00417-011-1760-3
Lin, C. M., & Gill, R. G. (2016). Direct and indirect allograft recognition: Pathways dictating graft rejection mechanisms. Current Opinion in Organ Transplantation, 21, 40–44. https://doi.org/10.1097/MOT.0000000000000263
Almoguera, B., Shaked, A., & Keating, B. J. (2014). Transplantation genetics: Current status and prospects. American Journal of Transplantation, 14, 764–778. https://doi.org/10.1111/ajt.12653
Djalilian, A. R., Mahesh, S. P., Koch, C. A., Nussenblatt, R. B., Shen, D., Zhuang, Z., et al. (2005). Survival of donor epithelial cells after limbal stem cell transplantation. Investigative Ophthalmology & Visual Science, 46, 803–807. https://doi.org/10.1167/iovs.04-0575
Medawar, P. B. (1948). Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. British Journal of Experimental Pathology, 29, 58–69.
Streilein, J. W. (2003). Ocular immune privilege: Therapeutic opportunities from an experiment of nature. Nature Reviews. Immunology, 3, 879–889. https://doi.org/10.1038/nri1224
Niederkorn, J. Y. (2006). See no evil, hear no evil, do no evil: The lessons of immune privilege. Nature Immunology, 7, 354–359. https://doi.org/10.1038/ni1328
Louveau, A., Harris, T. H., & Kipnis, J. (2015). Revisiting the mechanisms of CNS immune privilege. Trends in Immunology, 36, 569–577. https://doi.org/10.1016/j.it.2015.08.006
Engelhardt, B., Vajkoczy, P., & Weller, R. O. (2017). The movers and shapers in immune privilege of the CNS. Nature Immunology, 18, 123–131. https://doi.org/10.1038/ni.3666
Spadoni, I., Fornasa, G., & Rescigno, M. (2017). Organ-specific protection mediated by cooperation between vascular and epithelial barriers. Nature Reviews. Immunology, 17, 761–773. https://doi.org/10.1038/nri.2017.100
Tan, D. T. H., Dart, J. K. G., Holland, E. J., & Kinoshita, S. (2012). Corneal transplantation. Lancet, 379, 1749–1761. https://doi.org/10.1016/S0140-6736(12)60437-1
Amouzegar, A., Chauhan, S. K., & Dana, R. (2016). Alloimmunity and tolerance in corneal transplantation. Journal of Immunology, 196, 3983–3991. https://doi.org/10.4049/jimmunol.1600251
Niederkorn, J. Y. (2013). Corneal transplantation and immune privilege. International Reviews of Immunology, 32, 57–67. https://doi.org/10.3109/08830185.2012.737877
Casiraghi, F., Perico, N., & Remuzzi, G. (2017). Mesenchymal stromal cells for tolerance induction in organ transplantation. Human Immunology. https://doi.org/10.1016/j.humimm.2017.12.008
Hua, F., Chen, Y., Yang, Z., Teng, X., Huang, H., & Shen, Z. (2018). Protective action of bone marrow mesenchymal stem cells in immune tolerance of allogeneic heart transplantation by regulating CD45RB+ dendritic cells. Clinical Transplantation, 6, e13231. https://doi.org/10.1111/ctr.13231
Zou, L., Barnett, B., Safah, H., Larussa, V. F., Evdemon-Hogan, M., Mottram, P., et al. (2004). Bone marrow is a reservoir for CD4 +CD25 +regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Research, 64, 8451–8455. https://doi.org/10.1158/0008-5472.CAN-04-1987
Fujisaki, J., Wu, J., Carlson, A. L., Silberstein, L., Putheti, P., Larocca, R., et al. (2011). In vivo imaging of Treg cells providing 888 immune privilege to the haematopoietic stem-cell niche. Nature, 474, 216–219. https://doi.org/10.1038/nature10160
Hirata, Y., Furuhashi, K., Ishii, H., Li, H. W., Pinho, S., Ding, L., et al. (2018). CD150highbone marrow tregs maintain hematopoietic stem cell quiescence and immune privilege via adenosine. Cell Stem Cell, 22, 445–453.e5. https://doi.org/10.1016/j.stem.2018.01.017
Ksander, B. R., Kolovou, P. E., Wilson, B. J., Saab, K. R., Guo, Q., Ma, J., et al. (2014). ABCB5 is a limbal stem cell gene required for corneal development and repair. Nature, 511, 353–357. https://doi.org/10.1038/nature13426
Schatton, T., Yang, J., Kleffel, S., Uehara, M., Barthel, S. R., Schlapbach, C., et al. (2015). ABCB5 identifies immunoregulatory dermal cells. Cell Reports, 12, 1564–1574. https://doi.org/10.1016/j.celrep.2015.08.010
Sharpe, A. H., & Pauken, K. E. (2018). The diverse functions of the PD1 inhibitory pathway. Nature Reviews. Immunology, 18, 153–167. https://doi.org/10.1038/nri.2017.108
Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., et al. (2006). B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. Journal of Immunology, 177, 5928–5935.
Shen, L., Jin, Y., Freeman, G. J., Sharpe, A. H., & Dana, M. R. (2007). The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. Journal of Immunology, 179, 3672–3679.
Hori, J., & Streilein, J. W. (2001). Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Investigative Ophthalmology & Visual Science, 42, 1820–1828.
Hori, J., & Streilein, J. W. (2003). Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium. Investigative Ophthalmology & Visual Science, 44, 658–664.
Hori, J. (2008). Mechanisms of immune privilege in the anterior segment of the eye: What we learn from corneal transplantation. Journal of Ocular Biology, Diseases, and Informatics, 1, 94–100. https://doi.org/10.1007/s12177-008-9010-6
Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., et al. (2006). Corneal avascularity is due to soluble VEGF receptor-1. Nature, 443, 993–997. https://doi.org/10.1038/nature05249
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 270, 1189–1192.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997). CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. The Journal of Clinical Investigation, 99, 396–402. https://doi.org/10.1172/JCI119173
Takahashi, K., & Yamanaka, S. (2016). A decade of transcription factor-mediated reprogramming to pluripotency. Nature Reviews. Molecular Cell Biology, 17, 183–193. https://doi.org/10.1038/nrm.2016.8
Huang, L., Chen, M., Zhang, W., Sun, X., Liu, B., & Ge, J. (2018). Retinoid acid and taurine promote NeuroD1-induced differentiation of induced pluripotent stem cells into retinal ganglion cells. Molecular and Cellular Biochemistry, 438, 67–76. https://doi.org/10.1007/s11010-017-3114-x
Teotia, P., Van Hook, M. J., Wichman, C. S., Allingham, R. R., Hauser, M. A., & Ahmad, I. (2017). Modeling glaucoma: Retinal ganglion cells generated from induced pluripotent stem cells of patients with SIX6 risk allele show developmental abnormalities. Stem Cells, 35, 2239–2252. https://doi.org/10.1002/stem.2675
Kobayashi, W., Onishi, A., Tu, H. Y., Takihara, Y., Matsumura, M., Tsujimoto, K., et al. (2018). Culture systems of dissociated mouse and human pluripotent stem cell-derived retinal ganglion cells purified by two-step immunopanning. Investigative Ophthalmology & Visual Science, 59, 776–787. https://doi.org/10.1167/iovs.17-22406
Yokoi, T., Tanaka, T., Matsuzaka, E., Tamalu, F., Watanabe, S. I., Nishina, S., et al. (2017). Effects of neuroactive agents on axonal growth and pathfinding of retinal ganglion cells generated from human stem cells. Scientific Reports, 7, 16757. https://doi.org/10.1038/s41598-017-16727-1
Ramsden, C. M., Powner, M. B., Carr, A.-J. F., Smart, M. J., da Cruz, L., & Coffey, P. J. (2014). Neural retinal regeneration with pluripotent stem cells. Developments in Ophthalmology, 53, 97–110. https://doi.org/10.1159/000357363
Boucherie, C., Sowden, J. C., & Ali, R. R. (2011). Induced pluripotent stem cell technology for generating photoreceptors. Regenerative Medicine, 6, 469–479. https://doi.org/10.2217/rme.11.37
Kamao, H., Mandai, M., Okamoto, S., Sakai, N., Suga, A., Sugita, S., et al. (2014). Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports, 2, 205–218. https://doi.org/10.1016/j.stemcr.2013.12.007
Leach, L. L., & Clegg, D. O. (2015). Concise review: Making stem cells retinal: Methods for deriving retinal pigment epithelium and implications for patients with ocular disease. Stem Cells, 33, 2363–2373. https://doi.org/10.1002/stem.2010
Croze, R. H., & Clegg, D. O. (2014). Differentiation of pluripotent stem cells into retinal pigmented epithelium. Developments in Ophthalmology, 53, 81–96. https://doi.org/10.1159/000357361
Westenskow, P. D., Kurihara, T., & Friedlander, M. (2014). Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration. Advances in Experimental Medicine and Biology, 801, 323–329. https://doi.org/10.1007/978-1-4614-3209-8_41
Kamarudin, T. A., Bojic, S., Collin, J., Yu, M., Alharthi, S., Buck, H., et al. (2018). Differences in the activity of endogenous bone morphogenetic protein signaling impact on the ability of induced pluripotent stem cells to differentiate to corneal epithelial-like cells. Stem Cells, 36, 337–348. https://doi.org/10.1002/stem.2750
Zhao, T., Zhang, Z.-N., Rong, Z., & Xu, Y. (2011). Immunogenicity of induced pluripotent stem cells. Nature, 474, 212–215. https://doi.org/10.1038/nature10135
de Almeida, P. E., Meyer, E. H., Kooreman, N. G., Diecke, S., Dey, D., Sanchez-Freire, V., et al. (2014). Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nature Communications, 5, 3903. https://doi.org/10.1038/ncomms4903
Araki, R., Uda, M., Hoki, Y., Sunayama, M., Nakamura, M., Ando, S., et al. (2013). Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature, 494, 100–104. https://doi.org/10.1038/nature11807
Zhao, T., Zhang, Z.-N., Westenskow, P. D., Todorova, D., Hu, Z., Lin, T., et al. (2015). Humanized mice reveal differential immunogenicity of cells derived from autologous induced pluripotent stem cells. Cell Stem Cell, 17, 353–359. https://doi.org/10.1016/j.stem.2015.07.021
Hayashi, R., Ishikawa, Y., Sasamoto, Y., Katori, R., Nomura, N., Ichikawa, T., et al. (2016). Co-ordinated ocular development from human iPS cells and recovery of corneal function. Nature, 531, 376–380. https://doi.org/10.1038/nature17000
Ouyang, H., Xue, Y., Lin, Y., Zhang, X., Xi, L., Patel, S., et al. (2014). WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis. Nature, 511, 358–361. https://doi.org/10.1038/nature13465
Galindo, S., Herreras, J. M., Lopez-Paniagua, M., Rey, E., de la Mata, A., Plata-Cordero, M., et al. (2017). Therapeutic effect of human adipose tissue-derived mesenchymal stem cells in experimental corneal failure due to limbal stem cell niche damage. Stem Cells, 35, 2160–2174. https://doi.org/10.1002/stem.2672
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ksander, B.R., Frank, M.H., Frank, N.Y. (2018). Limbal Stem Cells and the Treatment of Limbal Stem Cell Deficiency. In: Ballios, B., Young, M. (eds) Regenerative Medicine and Stem Cell Therapy for the Eye. Fundamental Biomedical Technologies. Springer, Cham. https://doi.org/10.1007/978-3-319-98080-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-98080-5_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98079-9
Online ISBN: 978-3-319-98080-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)